Bortezomib Combined Chemotherapy for Children with Relapsed/refractory Acute Lymphoblastic Leukemia

被引：0
|
作者：
Sakaguchi, Hirotoshi [1 ]
Maemura, Ryo [1 ]
Yamamori, Ayako [1 ]
Wakamatsu, Manabu [1 ]
Yoshida, Nao [1 ]
Kato, Koji [1 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O29-3-1
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [41] Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael J.
    Ziegler, David S.
    Bautista, Francisco
    Attarbaschi, Andishe
    Gore, Lia
    Locatelli, Franco
    O'Brien, Maureen M.
    Pauly, Melinda
    Obreja, Mihaela
    Morris, Christopher L.
    Baruchel, Andre
    BLOOD, 2021, 138
  • [42] Phase 2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
    Ziegler, David S.
    Huynh, Van
    Burke, Michael J.
    Gore, Lia
    Locatelli, Franco
    O'Brien, Maureen M.
    Kim, Christopher
    Obreja, Mihaela
    Morris, Christopher L.
    Baruchel, Andre
    BLOOD, 2021, 138
  • [43] Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael J.
    Ziegler, David S.
    Bautista Sirvent, Francisco Jose
    Attarbaschi, Andishe
    Gore, Lia
    Locatelli, Franco
    O'Brien, Maureen M.
    Pauly, Melinda
    Obreja, Mihaela
    Morris, Christopher L.
    Baruchel, Andre
    BLOOD, 2019, 134
  • [44] The combination of bortezomib with chemotherapy to treatrelapsed/refractory acute lymphoblastic leukaemia of childhood
    Bertaina, Alice
    Vinti, Luciana
    Strocchio, Luisa
    Gaspari, Stefania
    Caruso, Roberta
    Algeri, Mattia
    Coletti, Valentina
    Gurnari, Carmelo
    Romano, Mariateresa
    Cefalo, Maria Giuseppina
    Girardi, Katia
    Trevisan, Valentina
    Bertaina, Valentina
    Merli, Pietro
    Locatelli, Franco
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) : 629 - 636
  • [45] Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience
    Barba, Pere
    Sampol, Antonia
    Calbacho, Maria
    Gonzalez, Jose
    Serrano, Josefina
    Martinez-Sanchez, Pilar
    Fernandez, Pascual
    Garcia-Boyero, Raimundo
    Bueno, Javier
    Maria Ribera, Josep
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (06) : 631 - 634
  • [46] Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial
    Zhang, Chengtao
    Gao, Da
    Wang, Xiaohong
    Sun, Xiuli
    Yan, Yan
    Yang, Yan
    Zhang, Jingjing
    Yan, Jinsong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [47] COMBINATION CHEMOTHERAPY IN RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    AMATO, KR
    SALLAN, SE
    LIPTON, JM
    CANCER TREATMENT REPORTS, 1984, 68 (02): : 411 - 412
  • [48] VM-26 AND CYTARABINE COMBINATION CHEMOTHERAPY IN REFRACTORY OR RELAPSED ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
    CARELLA, AM
    SANTINI, G
    MARTINENGO, M
    GIORDANO, D
    NATI, S
    CONGIU, A
    RISSO, M
    VIMERCATI, R
    CERRI, R
    ROSSI, E
    DAMASIO, E
    MARMONT, AM
    HAEMATOLOGICA, 1984, 69 (06) : 747 - 751
  • [49] Outcomes of Children with Relapsed Acute Lymphoblastic Leukemia in India
    Kulkarni, Ketan P.
    Marwaha, Ram Kumar
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 1101 - 1102
  • [50] A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Janssen, Julie M.
    Dorlo, T. P. C.
    Niewerth, D.
    Wilhelm, A. J.
    Zwaan, C. M.
    Beijnen, J. H.
    Attarbaschi, A.
    Baruchel, A.
    Fagioli, F.
    Klingebiel, T.
    De Moerloose, B.
    Palumbo, G.
    Von Stackelberg, A.
    Kaspers, G. J. L.
    Huitema, A. D. R.
    CLINICAL PHARMACOKINETICS, 2020, 59 (02) : 207 - 216
12345